RSA.L

RSA Insurance Group Plc
RSA Insurance Group - Director/PDMR Shareholding
26th May 2021, 14:31
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9357Z
RSA Insurance Group PLC
26 May 2021
 

RSA Insurance Group plc

("the Company")

 

Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")

 

Ordinary Shares of £1.00 each

 

26 May 2021

 

The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").

 

On 25 May 2021 the nil cost Conditional Awards over Shares granted under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below.

 

Name

No. of Performance Shares vested

No. of Dividend Equivalent Shares on Performance Shares

No. of Bonus

Deferral Shares Vested

No. of Dividend Equivalent Shares on Bonus Deferral Shares

No. of Restricted Shares Vested

Stephen Hester

1,030,213

37,617

322,071

4,261

-

Scott Egan

485,359

17,720

149,752

2,256

-

Martin Thompson

316,094

11,394

107,039

1,019

-

Ralph Daals

159,827

5,826

32,057

412

-

Charlotte Heiss

136,749

4,913

29,092

335

-

William McDonnell

168,716

6,238

42,851

511

-

Karen Caddick1

162,272

3,137

57,491

501

-

Charlotte Jones1,,

408,107

7,865

87,130

318

14,277

Nathan Williams

221,762

8,024

76,640

888

-

Kenneth Norgrove

108,466

4,206

59,391

939

-

 

·      Bonus Deferral Shares relate to awards made as part of the Annual Bonus Plan.

 

·      The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.

 

Notes to table:

1  Awards made to compensate for awards forfeited on leaving previous employer, in accordance with the Directors' Remuneration Policy, are included among those vesting.

 

 

The forms required under the EU Market Abuse Regulation follow.

 

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Stephen Hester

b)

Position / status

Group Chief Executive

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

1,030,213

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

1,030,213

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018,  8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

37,617

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

37,617

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

322,071

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

322,071

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

4,261

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

4,261

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Scott Egan

b)

Position / status

CEO, UK and International

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

485,359

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

485,359

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

17,720

d)

Aggregated information

-     Aggregated volume

-     Price

 

17,720

 

Nil

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

 

b)

 

Nature of the transaction

 

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

149,752

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

149,752

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

2,256

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

2,256

Nil

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Martin Thompson

b)

Position / status

CEO, Canada

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

316,094

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

316,094

 

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

11,394

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

11,394

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

107,039

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

107,039

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

1,019

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

1,019

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Ralph Daals

b)

Position / status

Group Chief Auditor

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

 

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

159,827

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

159,827

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

 

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

5,826

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

5,826

NIL

 

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

32,057

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

32,057

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

412

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

412

 

NIL

 

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Charlotte Heiss

b)

Position / status

Group General Counsel and Company Secretary

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

136,749

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

136,749

 

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

4,913

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

4,913

 

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

29,092

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

29,092

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

 

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

335

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

335

 

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

William McDonnell

b)

Position / status

Group Chief Risk Officer

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

168,716

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

168,716

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

6,238

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

6,238

 

NIL

 

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

42,851

 

 

d)

 

 

Aggregated information

-     Aggregated volume

-     Price

 

 

 

 

42,851

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

511

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

511

 

NIL

 

e)

Date of the transaction

25 May 2021

 

f)

 

Place of the transaction


 

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Karen Caddick

b)

Position / status

Group & UK HR Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

162,272

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

162,272

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

3,137

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

3,137

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 2 September 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

57,491

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

57,491

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 2 September 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

501

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

501

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Charlotte Jones

b)

Position / status

Group Chief Financial Officer

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

408,107

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

408,107

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 September 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

7,865

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

7,865

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

87,130

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

87,130

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on  6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

318

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

318

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Restricted Share awards granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

14,277

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

14,277

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Nathan Williams

b)

Position / status

Group Underwriting Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

221,762

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

221,762

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Performance Share awards on 2 March 2018, 8 March 2019 & 6 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

8,024

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

8,024

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

76,640

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

 

76,640

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019, 6 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

888

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

 

888

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

Kenneth Norgrove

b)

Position / status

CEO RSA Scandinavia

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share awards granted on 2 March 2018, 8 March 2019 & 16 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

108,466

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

108,466

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Performance Share awards on 2 March 2018 & 8 March 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

4,206

d)

Aggregated information

-     Aggregated volume

-     Price

 

4,206

 

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share awards granted on 8 March 2019, 16 March 2020 & 8 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

59,391

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

59,391

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share awards granted as part of the Bonus Deferral Share awards on 8 March 2019 &16 March 2020 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to the awards at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

939

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

939

NIL

e)

Date of the transaction

25 May 2021

f)

Place of the transaction

XLON London Stock Exchange

 

 

 

Enquiries to:

 

Christopher Smyth, Deputy Group Company Secretary

RSA Insurance Group plc

Tel:  +44 (0) 20 7111 7000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZQLFLFELLBBD ]]>
TwitterFacebookLinkedIn